Equities

J Frontier Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

J Frontier Co Ltd

Actions
Health CareHealth Care Providers
  • Price (JPY)1,335.00
  • Today's Change-33.00 / -2.41%
  • Shares traded3.40k
  • 1 Year change-33.38%
  • Beta1.0720
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.

  • Revenue in JPY (TTM)21.34bn
  • Net income in JPY-111.68m
  • Incorporated2008
  • Employees202.00
  • Location
    J Frontier Co Ltd4F, KN Shibuya 3, 9-8, Sakuragaoka-choSHIBUYA-KU 150-0031JapanJPN
  • Phone+81 364274662
  • Fax+81 364275969
  • Websitehttps://jfrontier.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
2934:TYO since
announced
Transaction
value
Shake-HandsDeal completed27 Aug 202527 Aug 2025Deal completed-28.11%8.38m
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Creema Ltd2.49bn38.98m1.66bn79.0042.681.5420.730.66885.795.79369.34160.700.7194--4.6531,507,770.001.131.063.012.8779.6485.351.571.54--20.110.29550.00-0.07810.5630.17---53.46--
Yumemitsuketai Co Ltd308.06m134.97m2.15bn10.0015.440.784322.726.9913.3413.3430.45262.660.09040.176716.9630,805,900.003.963.164.624.0359.6050.3843.8122.900.114--0.19970.00-53.58-13.45-35.50------
P-Ban.Com Corp2.27bn132.66m2.55bn40.0018.151.6916.371.1328.2228.22481.87302.231.3262.627.8856,644,920.007.747.369.559.1337.7734.035.865.714.27122.060.016634.118.180.43920.640.1199-13.3214.87
Micreed Co Ltd7.42bn286.00m3.16bn28.0011.041.979.120.425343.1943.191,120.39242.662.8215.547.66264,928,600.0010.866.0218.349.3434.2134.113.862.121.87--0.0020.5314.1510.7216.2219.7035.8946.52
Tea Life Co Ltd11.22bn336.00m4.94bn144.0014.670.77529.890.440178.7478.742,628.111,490.041.277.5512.0577,881,940.003.826.014.457.1936.4437.853.004.093.36--0.123140.06-11.531.6912.23-3.18-46.635.92
TransGenic Group Inc12.89bn-769.96m5.03bn241.00--0.9973--0.3903-46.24-46.24774.19296.811.244.038.1353,496,540.00-7.541.81-12.152.4817.8221.30-6.081.431.11--0.365730.95-0.59873.32-26,774.20---7.33--
Kuradashi Co Ltd3.20bn40.69m5.16bn39.00114.633.3833.821.613.713.71283.83125.811.1616.7516.0182,176,740.001.47--2.09--47.57--1.27--1.6819.850.4997--7.47---348.89------
J Frontier Co Ltd21.34bn-111.68m7.12bn202.00--5.0711.650.3337-20.05-20.054,110.19263.232.256.1314.90105,624,200.00-1.13-9.12-2.78-17.9542.1648.48-0.5043-3.850.7212--0.707--21.3924.79104.20-1.9064.48--
Crooz Inc11.71bn-370.49m7.41bn712.00--0.6155--0.633-38.71-38.711,222.99929.280.377614.064.9716,444,680.00-1.201.75-1.482.2750.5236.58-3.182.471.88-12.700.6860.00-0.5516-16.03-152.61---6.78--
Hamee Corp23.45bn912.13m7.85bn489.008.430.69294.360.334957.0957.091,467.97694.161.292.178.6047,955,960.005.0111.417.9015.5359.4160.913.898.271.3811.130.316823.9630.0015.1213.943.633.8226.30
Felissimo Corp29.52bn577.00m8.26bn419.0010.690.31655.710.2881.0181.014,144.562,736.081.022.799.3570,453,460.001.991.832.632.5854.4753.591.951.831.94--0.0018.35-0.53370.5819115.85-17.92-11.5024.57
Senshukai Co Ltd42.07bn3.94bn10.83bn871.002.470.57112.410.257484.2384.23899.41364.221.623.7342.60--15.17-7.8423.86-11.8350.7149.829.37-5.651.34-29.750.0176---7.74-12.77207.71---23.93--
Papyless Co Ltd14.77bn146.00m10.89bn158.0063.061.01167.610.737616.7316.731,679.301,049.351.07--9.7793,487,340.000.40014.180.57816.4046.8548.780.37243.04----0.0015.72-8.19-7.55-175.58---9.710.00
Data as of Feb 13 2026. Currency figures normalised to J Frontier Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

2.53%Per cent of shares held by top holders
HolderShares% Held
Meiji Yasuda Asset Management Co. Ltd.as of 13 Dec 2024131.40k2.47%
Simplex Asset Management Co., Ltd.as of 08 Jan 20263.10k0.06%
Nomura Asset Management Co., Ltd.as of 29 Oct 20240.000.00%
Fivestar Asset Management Co. Ltd.as of 25 Oct 20240.000.00%
More ▼
Data from 24 Mar 2025 - 03 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.